Neurocrine
Business Services · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.neurocrinemedical.comRevenue
<$5 MillionIndustry
About Neurocrine
Neurocrine Org Chart
Is Neurocrine your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Neurocrine had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Neurocrine is spiking on competitors!
Neurocrine, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Neurocrine recently announced quarterly report
Product Launch: Get notified when Neurocrine launches new products
Funding: Get notified immidiatlly once Neurocrine has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Neurocrine
Check if Neurocrine has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Neurocrine
Find more new buyers
Compare Similar Companies to Neurocrine
Compare insights from companies similar to Neurocrine, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Neurocrine is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Neurocrine is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Neurocrine.
Neurocrine Tech Stack
A closer look at the technologies used by Neurocrine
Neurocrine News & Media
Neurocrine Biosciences, Inc. (NBIX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neurocrine Biosciences, Inc. (NBIX) Bank of America Global Healthcare Conference 2026 May 12, 2026 2:20 PM EDTCompany ParticipantsTodd TushlaMatthew...Neurocrine to acquire Soleno in $2.9bn transaction
The acquisition allows Neurocrine to offer three therapies: Ingrezza, Crenessity, and Vykat XR.Neurocrine to Buy Soleno for Treatment for Rare Disease That Causes Relentless Hunger
Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio.
Top Business Services Companies
Frequently Asked Questions Regarding Neurocrine
Neurocrine Medical Affairs focuses on providing scientific communication and resources related to neurologic, psychiatric, and endocrine disorders. The company serves healthcare professionals in the United States by offering access to an extensive library of scientific materials and support for independent medical education and research. Their serv... Read More